

| CHRISTIAN DIOR SE | 14/05/2009 AGM | |
|---|---|---|
| 1 | Approve the parent company's financial statements | For |
| 2 | Approve Consolidated Financial Statements | For |
| 3 | Approval of regulated related-party agreements | Oppose |
| 4 | Approval of the appropriation of income and of the dividend | For |
| 5 | Election of Mr. renaudDonnedieu de Vabres as Director for a period of 1 year | Oppose |
| 6 | Reappointment of Mr. Eric Guerlain as Director for a period of 3 years | Oppose |
| 7 | Reappointment of Mr. Antoine Bernheim as Director for a period of 3 years | Oppose |
| 8 | Reappointment of Mr. Denis Dalibot as Director for a period of 3 year | Oppose |
| 9 | Reappointment of Mr. Christian de Labriffe as Director for a period of 3 years | Oppose |
| 10 | Reappointment of Mr Jaime de Marichar y Saenz de Tejada as Director for a period of 3 years | Oppose |
| 11 | Reappointment of Mr. Alessandro Vallarino Gancia as Director for a period of 3 years | Oppose |
| 12 | Reappointment as Statutory External Auditor of Ernst & Young Autres for a period of 6 years | For |
| 13 | Elect Auditex as Substitute External Auditor for a period of 6 years | Oppose |
| 14 | Reappointment of Mazars & Guérard as Statutory External Auditor for a period of 6 years | For |
| 15 | Elect Mr Guillaume Potel as Substitute External Auditor for a period of 6 years | Oppose |
| 16 | Approve buy-back of the company shares | For |
| 17 | Approve potential reduction of the company 's capital | Oppose |
| 18 | 1)Global authorization to issue with pre-emptive subscription right shares or other securities giving way to new capital; 2)Increase authorized capital by transfer of reserves | For |
| 19 | Global allowance for the issuance of capital related securities without pre-emptive right | Oppose |
| 20 | "Green shoe" authorization | Oppose |
| 21 | Approve issues of shares or other capital related securities as a payment for any public offer | Oppose |
| 22 | Delegation to issue shares and capital securities as consideration for contributions in kind made to the company | Oppose |
| 23 | Approve issuance of new stock option plans (new shares) | Oppose |
| 24 | Change by-laws provisions following legal changes | Oppose |